-Outlook A scheme to credit kerosene subsidies to beneficiaries’ accounts flopped real big in Rajasthan Dharamvir Chaudhary’s fair price shop in Kot Kasim, Rajasthan, is deserted. A year ago the tehsil played host to an experiment by the government: residents were asked to buy kerosene—a fuel most of India’s poor use to cook and light lamps—at market price (Rs 50 a litre) from shops like Dharamvir’s. People were promised that the...

-The Hindu To many in Idinthakarai, the village that sits cheek by jowl with the nuclear plant, the entire idea is a betrayal. Others see brighter prospects. As the reactor prepares to go critical, Meera Srinivasan assesses the mood in the project area. Seated at the entrance to her tiny home, R. Pramasakthi is busy rolling beedis. “What? Interview? We don’t need the nuclear plant,” she barked. Asked why, the 35-year-old mother of...

-The Times of India The next time you apologize for your home looking like a dump, spare a thought for Shobhraj Kumar. Most people who hurry past the garbage dump at Masjid Moth would find it difficult to stand there for a few minutes because of the all-pervading stench. But for Shobhraj and his family of six, the dump is home. The 62-year-old says he has been living in the 20 sq...

-Deccan Herald Cash transfer for public schemes is a “terrible lie”, said activists at a meeting held at Jantar Mantar on Wednesday. Communist Party of India (Marxist) leader Brinda Karat said that if one compared India with African countries, India would beat them in terms of poverty. “The government is not willing to tax business tycoons and is making the common man suffer by cutting down subsidies,” she said. Karat added that her...

-The Times of India A once-a-week medicine for diabetics — a disease that affects nearly 63 million Indians — could soon become a reality. Studies on diabetes have seen a global upsurge, with the latest data showing that bio-pharmaceutical research companies across the globe are busy developing 221 innovative new medicines. The drugs, which will help around 347 million patients include new therapies that target key abnormalities of pancreatic cells, increase insulin secretion...